Doxepin Hydrochloride

Product NDC
51672-1404
Requested package NDC
51672-1404-9
11-digit product format
516721404
Labeler code
51672
Product ID
51672-1404_5c03e1c3-1884-0855-e063-6294a90a8a1b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Doxepin Hydrochloride
Dosage form
CREAM
Route
TOPICAL
Labeler
Sun Pharmaceutical Industries, Inc.
Application
ANDA213919
Marketing category
ANDA
Marketing start
2026-09-30
Substance
DOXEPIN HYDROCHLORIDE
Active strength
50 mg/g
Pharmacologic classes
Tricyclic Antidepressant [EPC]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A213919-001DOXEPIN HYDROCHLORIDEDOXEPIN HYDROCHLORIDE5%CREAM / TOPICALAB2026-04-28

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A213919-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A213919-001DOXEPIN HYDROCHLORIDE5%CREAM / TOPICALAB2026-04-28d4dbc9d85df4…
2026-10-15 13:18:302026-09A213919-001DOXEPIN HYDROCHLORIDE5%CREAM / TOPICALAB2026-04-28c2088c7a36db…
2026-09-14 22:38:342026-08A213919-001DOXEPIN HYDROCHLORIDE5%CREAM / TOPICALAB2026-04-2884e616aacf4f…
2026-08-18 06:07:402026-07A213919-001DOXEPIN HYDROCHLORIDE5%CREAM / TOPICALAB2026-04-28caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213919-001DOXEPIN HYDROCHLORIDE5%CREAM / TOPICALAB2026-04-28a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A213919-001AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A213919-001AB1c2088c7a36db…
2026-09-14 22:38:342026-08A213919-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A213919-001AB1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A213919-001AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Doxepin Hydrochloride
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DOXEPIN HYDROCHLORIDE50 mg/g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
3U9A0FE9N5Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1000091Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0d4bff5c-4e3d-459e-aba2-9c4c34b5ba7bAvailable on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Doxepin HydrochlorideDOXEPIN HYDROCHLORIDESun Pharmaceutical Industries, Inc.0d4bff5c-4e3d-459e-aba2-9c4c34b5ba7b2026-09-21Warnings, Adverse reactionsExact identifier
application applno (ANDA): 213919
application number: ANDA213919
ndc (package): 51672-1404-9
ndc (product): 51672-1404
ndc11 (package): 51672140409

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
51672-1404-9516721404091 TUBE in 1 CARTON (51672-1404-9) / 45 g in 1 TUBE1 tube2026-09-30NoNoCurrent